
Conversation Series | Innovations in Treatments for ED with Dr. Tom Silva
In the latest video from our Conversation Series, specialist GP Dr. Tom Silva discusses crucial considerations in clinical practice with regards to ED treatment selection

Quarterly Activities Report and 4C
LTR Pharma has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 31 December 2024. Key highlights

LTR Pharma Signs National Pharmacy Distribution Agreement with Symbion
LTR Pharma is pleased to announce it has entered into an agreement with Symbion Pty Ltd, a leading pharmaceutical wholesaler in Australia, to establish national

Agreement with Australia’s leading Men’s Health Pharmacy for access to SPONTAN®
LTR Pharma is pleased to announce it has entered into an access agreement with Men’s Health Downunder (MHDU) to facilitate access to SPONTAN® through the

Early Launch of Online Men’s Health Platform
LTR Pharma’s joint venture partner Restorative Health Clinic has today launched its online men’s health platform ahead of schedule, delivering comprehensive telehealth services to Australian

LTR Pharma completes A$25 million placement to expedite commercialisation of SPONTAN®
LTR Pharma has today announced that it has successfully completed a A$25 million placement to sophisticated and institutional investors to accelerate SPONTAN®’s commercialisation. These funds